Marwan N. Sabbagh

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

Stephen Salloway, Reisa A. Sperling, Nick C. Fox et al. · New England Journal of Medicine · 2014 · 2K citations · Full text

Medicine, Neurology, Pharmacology +17

Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

Yasser Iturria‐Medina, Roberto C. Sotero, P.-J. Toussaint et al. · Nature Communications · 2016 · 1.2K citations · Full text

Life Sciences, Neurology, Neuroscience +17

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

Christopher M. Clark, Michael J. Pontecorvo, Thomas G. Beach et al. · The Lancet Neurology · 2012 · 848 citations

Life Sciences, Neurology, Neuroscience +16

Alzheimer's disease drug development pipeline: 2019

Jeffrey L. Cummings, Garam Lee, Aaron Ritter et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2019 · 763 citations · Full text

Medicine, Pharmacology, Dementia +14

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

Osama Sabri, Marwan N. Sabbagh, John Seibyl et al. · Alzheimer s & Dementia · 2015 · 609 citations · Full text

Medicine, Neurology, Nuclear Medicine +17